BioXcel Therapeutics
BTAI
BTAI
36 hedge funds and large institutions have $32.6M invested in BioXcel Therapeutics in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.19% more ownership
Funds ownership: 1% → 1.2% (+0.19%)
Holders
36
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.02M | |
| 2 | +$857K | |
| 3 | +$679K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$372K |
| 5 |
Squarepoint
New York
|
+$340K |
Top Sellers
| 1 | -$1.42M | |
| 2 | -$154K | |
| 3 | -$127K | |
| 4 |
Morgan Stanley
New York
|
-$25.6K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$9.49K |